News Detail

London, 17 Nov 2022: Cambridge biologists utilized synthetic biology to produce artificial enzymes designed to target the SARS-CoV-2 genetic code and kill the virus, a strategy that might be exploited to create an entirely new era of antiviral medications.
......
View Details
Source : Science Times
synthetic biology
virus
sars
medicine
Protein
CoViD-19
Related News
- Gut bacteria affect brain health, mouse study shows (14-01-2023)
- A New Weapon Edoxudine Against Antibiotic-Resistant Bacteria (08-01-2023)
- Rheumatoid Arthritis Drugs Lower Risk of Heart Disease (10-12-2022)
- Researchers discover new form of antimicrobial resistance (02-12-2022)
- Study shows superbugs in the environment rarely transfer over to humans (23-11-2022)
- Do herbal supplements of Ginkgo biloba impact course of tinnitus? (22-11-2022)
- 5 bacteria types claimed 6.8 lakh lives in India in 2019: Report (22-11-2022)
- Antibiotic misuse for common sore throat, fuelling the 3rd leading cause of death worldwide: Study (20-11-2022)
- Uterine fibroid growth activated by phthalates found in everyday products (15-11-2022)
- Screening for Prostate Cancer among Men who use Statins, results (15-11-2022)